March 09, 2016, Princeton, New Jersey: Navitas’ inaugural pvindia meeting took place in Mumbai on Thursday 03 March, 2016. The event was well attended with 25 drug safety professionals representing 14 pharmaceutical companies; both Indian headquartered as well as global.
pvindia is a membership based network for Heads of Safety of Indian life sciences companies with pharma, consumer, generics, or mixed portfolios. The network provides an opportunity for members to meet and discuss some of the industry’s common challenges relating to pharmacovigilance. Membership to the network provides.
- A neutral platform for Heads of Safety in India to meet
- A peer-to-peer network and insight exchange
- A focus on member interests; debating ‘top of mind’ issues
- A platform to share and develop strategies and best practices
- An opportunity to build profile and industry voice
Key discussion topics on the day included the global harmonisation of regulations as well as looking at how companies adapt to a variety of international regulations and inspection readiness.
Dr. K Bangarurajan, Deputy Drugs Controller of the CDSCO West presented the keynote speech at the meeting and commented: ‘I am glad to be a part of the inaugural meet of pvindia. At times when Indian companies, like their colleagues in the US and EU, are frequented by Inspectors of internal Health Authorities, there exists significant strain on any organisation. Being prepared for any inspection is a priority for the Indian Pharmaceutical Industry in such scenarios. pvindia will help companies to prepare for inspections triggered by these regulations.’
The next pvindia event is planned for October, 2016. Further information will follow in due course.